CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
EirGenix Inc Company Snapshot
EirGenix Inc operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares EirGenix Inc with three other companies in this sector in Taiwan: Mycenax Biotech Incorporated (2018 sales of 211.42 million Taiwanese Dollars [US$6.93 million] of which 100% was Biological Drug Development), Genmont Biotech Inc (406.53 million Taiwanese Dollars [US$13.33 million] of which 100% was Jingyue Company), and Abnova (Taiwan) Corporation (426.02 million Taiwanese Dollars [US$13.97 million] of which 27% was Monoclonal Antibodies).

Sales Analysis. EirGenix Inc reported sales of 282.21 million Taiwanese Dollars (US$9.25 million) for the year ending December of 2018. This represents a decrease of 5.3% versus 2017, when the company's sales were 297.87 million Taiwanese Dollars.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
EirGenix Inc
  Stock Performance Chart for EirGenix Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 27.65
(Figures in Taiwanese Dollars)
1 Week -0.4%   13 Weeks -7.5%  
4 Weeks -8.6%   52 Weeks -11.1%  
 
EirGenix Inc Key Data:
  Ticker: 6589 Country: Taiwan
  Exchanges: TAI Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 282,209,000
(Year Ending Jan 2019).
Employees: 179
  Currency: Taiwanese Dollars Market Cap: 4,680,923,800
  Fiscal Yr Ends: December Shares Outstanding: 169,292,000
  Share Type: GU Closely Held Shares: N/A
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.